Format

Send to

Choose Destination
See comment in PubMed Commons below
Case Rep Med. 2012;2012:358024. doi: 10.1155/2012/358024. Epub 2012 Oct 9.

Thrombocytopenia in the setting of hemodialysis using biocompatible membranes.

Author information

1
School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.

Abstract

Thrombocytopenia is a known potential side effect of hemodialysis, however, it is rarely seen in patients who undergo hemodialysis using biocompatible membranes. This case demonstrates hemodialysis-associated thrombocytopenia with use of biocompatible dialysis membranes that expose blood directly to polysulfone. The thrombocytopenia resolved in this patient when the dialysis membrane was changed to a biocompatible model with a polyethylene glycol barrier layer preventing direct interaction between patient blood and polysulfone. The calculated Naranjo ADR score of 9 indicates a highly probable adverse reaction.

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Support Center